Skip to main content
Erschienen in: World Journal of Surgery 10/2007

01.10.2007

Extramammary Paget’s Disease in Chinese Males: A 21-year Experience

verfasst von: Tor W. Chiu, Pauline S. Y. Wong, Kawser Ahmed, Stephanie C. K. Lam, Shun Y. Ying, Andrew Burd

Erschienen in: World Journal of Surgery | Ausgabe 10/2007

Einloggen, um Zugang zu erhalten

Abstract

Background

Extramammary Paget’s disease (EMPD) is a rare disease in Chinese males. Our objectives were to examine the results of our experience, to correlate them with the published literature, and thus to formulate improved management guidelines.

Methods

This was a retrospective analysis of all male patients with EMPD treated at our institution. We reviewed the patients and their case notes for data such as presenting symptoms, delay to diagnosis, incidence of concurrent malignancies, treatments given, and a variety of outcome measures, including the number of patients with recurrent or residual disease.

Results

The overall recurrence rate was 35%. The risk of recurrence was reduced if intraoperative frozen section analysis was used (25%) compared to simple wide local excision (60%). Wide local excision failed to excise the disease completely in 38%. There were no associated internal malignancies and no disease-related deaths in our sample.

Conclusions

We recommend intraoperative frozen sections to reduce the risk of incomplete resection and to reduce the rate of recurrence. In our population, screening for internal malignancies can be restricted to select patients, e.g., those with perianal disease, those with invasive disease, and young patients.
Literatur
1.
Zurück zum Zitat Pitman GH, McCarthy JG, Perzin KH, et al. (1982) Extramammary Paget’s disease. Plast Reconstr Surg 69:238–244PubMedCrossRef Pitman GH, McCarthy JG, Perzin KH, et al. (1982) Extramammary Paget’s disease. Plast Reconstr Surg 69:238–244PubMedCrossRef
2.
Zurück zum Zitat Zollo JD, Zeitouni NC (2000) The Roswell Park Cancer Institute experience with extramammary Paget’s disease. Br J Dermatol 142:59–42PubMedCrossRef Zollo JD, Zeitouni NC (2000) The Roswell Park Cancer Institute experience with extramammary Paget’s disease. Br J Dermatol 142:59–42PubMedCrossRef
3.
Zurück zum Zitat Besa P, Rich TA, Delclos L, et al. (1992) Extramammary Paget’s disease of the perineal skin: role of radiotherapy. Int J Radiat Oncol Biol Phys 24:73–78PubMed Besa P, Rich TA, Delclos L, et al. (1992) Extramammary Paget’s disease of the perineal skin: role of radiotherapy. Int J Radiat Oncol Biol Phys 24:73–78PubMed
4.
Zurück zum Zitat van Randenburgh H, Paul R, Nahrig J, et al. (2002) Extramammary Paget’s disease of the penis and scrotum. J Urol 168:2540–2541CrossRef van Randenburgh H, Paul R, Nahrig J, et al. (2002) Extramammary Paget’s disease of the penis and scrotum. J Urol 168:2540–2541CrossRef
5.
Zurück zum Zitat Park S, Grossfeld GD, McAninch JW, et al. (2001) Extramammary Paget’s disease of the penis and scrotum: excision, reconstruction and evaluation of occult malignancy. J Urol 16:2112–2117 Park S, Grossfeld GD, McAninch JW, et al. (2001) Extramammary Paget’s disease of the penis and scrotum: excision, reconstruction and evaluation of occult malignancy. J Urol 16:2112–2117
6.
Zurück zum Zitat Bansal D, Bowman CA (2004) Extramammary Paget’s disease masquerading as lichen sclerosus. Int J STD AIDS 15:141–142PubMedCrossRef Bansal D, Bowman CA (2004) Extramammary Paget’s disease masquerading as lichen sclerosus. Int J STD AIDS 15:141–142PubMedCrossRef
7.
Zurück zum Zitat De Blois M, Patterson JW, Hunter SB (1984) Extramammary Paget’s disease. Arch Pathol Lab Med 108:713–716PubMed De Blois M, Patterson JW, Hunter SB (1984) Extramammary Paget’s disease. Arch Pathol Lab Med 108:713–716PubMed
8.
Zurück zum Zitat Jones RE, Austin C, Ackerman AB (1979) Extramammary Paget’s disease: Arising in knee region in association with sweat gland carcinoma. Am J Dermatopathol 1:101–132PubMed Jones RE, Austin C, Ackerman AB (1979) Extramammary Paget’s disease: Arising in knee region in association with sweat gland carcinoma. Am J Dermatopathol 1:101–132PubMed
9.
Zurück zum Zitat Urabe A, Matsukuma A, Shimizu N, et al. (1990) Extramammary Paget’s disease. J Cutan Pathol 17:257–265PubMedCrossRef Urabe A, Matsukuma A, Shimizu N, et al. (1990) Extramammary Paget’s disease. J Cutan Pathol 17:257–265PubMedCrossRef
10.
Zurück zum Zitat Koss LG, Ladinsky S, Brockunier A (1968) Paget’s disease of the vulva: report of ten cases. Obstet Gynecol 31:513–525PubMed Koss LG, Ladinsky S, Brockunier A (1968) Paget’s disease of the vulva: report of ten cases. Obstet Gynecol 31:513–525PubMed
11.
Zurück zum Zitat Hamm H, Vroom TM, Czarnetzki BM (1986) Extramammary Paget’s cells: Further evidence of sweat gland derivation. J Am Acad Dermatol 15:1275–1281PubMedCrossRef Hamm H, Vroom TM, Czarnetzki BM (1986) Extramammary Paget’s cells: Further evidence of sweat gland derivation. J Am Acad Dermatol 15:1275–1281PubMedCrossRef
12.
Zurück zum Zitat Helwig EB, Graham JH (1963) Anogenital (extramammary) Paget’s disease: a clinicopathological study. Cancer 16:387–403PubMedCrossRef Helwig EB, Graham JH (1963) Anogenital (extramammary) Paget’s disease: a clinicopathological study. Cancer 16:387–403PubMedCrossRef
13.
Zurück zum Zitat Merot Y, Mazoujian G, Pinkus G, et al. (1985) Extramammary Paget’s disease of the perianal and perineal regions. Arch Dermatol 121:750–752PubMedCrossRef Merot Y, Mazoujian G, Pinkus G, et al. (1985) Extramammary Paget’s disease of the perianal and perineal regions. Arch Dermatol 121:750–752PubMedCrossRef
14.
Zurück zum Zitat Lloyd J, Flanagan AM (2000) Mammary and extramammary Paget’s disease. J Clin Pathol 53:742–749PubMedCrossRef Lloyd J, Flanagan AM (2000) Mammary and extramammary Paget’s disease. J Clin Pathol 53:742–749PubMedCrossRef
15.
Zurück zum Zitat Smith AA, Silver TM (2003) Zirconyl haematoxylin vs alcian blue staining in a case of Extramammary Paget’s disease. J Cutan Pathol 30:401–404PubMedCrossRef Smith AA, Silver TM (2003) Zirconyl haematoxylin vs alcian blue staining in a case of Extramammary Paget’s disease. J Cutan Pathol 30:401–404PubMedCrossRef
16.
Zurück zum Zitat Anthony PP, Freeman K, Warin AP (1986) Extramammary Paget’s disease. Clin Exp Dermatol 11:387–395PubMedCrossRef Anthony PP, Freeman K, Warin AP (1986) Extramammary Paget’s disease. Clin Exp Dermatol 11:387–395PubMedCrossRef
17.
Zurück zum Zitat Brown RS, McCormack M, Lankester KJ et al. (2000) Spontaneous apparent clinical resolution with histologic persistence of a case of extramammary Paget’s disease: response to topical 5-fluorouracil. Cutis 66:454PubMed Brown RS, McCormack M, Lankester KJ et al. (2000) Spontaneous apparent clinical resolution with histologic persistence of a case of extramammary Paget’s disease: response to topical 5-fluorouracil. Cutis 66:454PubMed
18.
Zurück zum Zitat Ramalingam P, Hart WR, Goldblum JR (2001) Cytokeratin subset immunostaining in rectal adenocarcinoma and normal anal glands. Arch Pathol Lab Med 125:1074–1077PubMed Ramalingam P, Hart WR, Goldblum JR (2001) Cytokeratin subset immunostaining in rectal adenocarcinoma and normal anal glands. Arch Pathol Lab Med 125:1074–1077PubMed
19.
Zurück zum Zitat Ogawa T, Nagashima Y, Wada H, et al. (2005) Extramammary Paget’s disease: analysis of growth signal pathway for human epidermal growth factor receptor 2 protein. Human Pathol 36:1273–1280 Ogawa T, Nagashima Y, Wada H, et al. (2005) Extramammary Paget’s disease: analysis of growth signal pathway for human epidermal growth factor receptor 2 protein. Human Pathol 36:1273–1280
20.
Zurück zum Zitat Reich O, Liegl B, Tamussino K, et al. (2005) P185 (HER 2) overexpression and HER 2 oncogene amplication in recurrent vulvar Paget’s disease. Mod Pathol 18:354–357PubMedCrossRef Reich O, Liegl B, Tamussino K, et al. (2005) P185 (HER 2) overexpression and HER 2 oncogene amplication in recurrent vulvar Paget’s disease. Mod Pathol 18:354–357PubMedCrossRef
21.
Zurück zum Zitat Kuivanen T, Tanskanen M, Jahkola T, et al. (2004) Matrilysin-1 (MMP-7) and MMP-19 are expressed by Paget’s cells in extramammary Paget’s disease. J Cutan Pathol 31:483–491PubMedCrossRef Kuivanen T, Tanskanen M, Jahkola T, et al. (2004) Matrilysin-1 (MMP-7) and MMP-19 are expressed by Paget’s cells in extramammary Paget’s disease. J Cutan Pathol 31:483–491PubMedCrossRef
22.
Zurück zum Zitat Kuan SF, Montag AG, Hart J, et al. (2002) Differential expression of mucin genes in mammary and extramammary Paget’s disease. Am J Surg Pathol 26:617–623CrossRef Kuan SF, Montag AG, Hart J, et al. (2002) Differential expression of mucin genes in mammary and extramammary Paget’s disease. Am J Surg Pathol 26:617–623CrossRef
23.
Zurück zum Zitat Ojeda VJ, Heenan PJ, Watson SH (1987) Paget’s disease of the groin associated with adenocarcinoma of the urinary bladder. J Cutan Pathol 14:227–231PubMedCrossRef Ojeda VJ, Heenan PJ, Watson SH (1987) Paget’s disease of the groin associated with adenocarcinoma of the urinary bladder. J Cutan Pathol 14:227–231PubMedCrossRef
24.
Zurück zum Zitat Salamania J, Benito A, Garcia-Penalver C, et al. (2004) Paget’s disease of the glans penis secondary to transitional cell carcinoma of the bladder: a report of 2 cases and a review of the literature. J Cutan Pathol 31:341–345CrossRef Salamania J, Benito A, Garcia-Penalver C, et al. (2004) Paget’s disease of the glans penis secondary to transitional cell carcinoma of the bladder: a report of 2 cases and a review of the literature. J Cutan Pathol 31:341–345CrossRef
25.
Zurück zum Zitat Young DC, Nam HC, Young SP, et al. (2005) Lymphovascular and marginal invasion as useful prognostic indicators and the role of c-erbB-2 in patients with male extramammary Paget’s disease: a study of 31 patients. J Urol 174:561–565CrossRef Young DC, Nam HC, Young SP, et al. (2005) Lymphovascular and marginal invasion as useful prognostic indicators and the role of c-erbB-2 in patients with male extramammary Paget’s disease: a study of 31 patients. J Urol 174:561–565CrossRef
26.
Zurück zum Zitat Chang YT, Liu HN, Wong CK (1996) Extramammary Paget’s disease: A report of 22 cases in Chinese males. J Dermatol 23:320PubMed Chang YT, Liu HN, Wong CK (1996) Extramammary Paget’s disease: A report of 22 cases in Chinese males. J Dermatol 23:320PubMed
27.
Zurück zum Zitat Chanda JJ (1985) Extramammary Paget’s disease: prognosis and relationship to internal malignancy J Am Acad Dermatol 13:1009–1014PubMedCrossRef Chanda JJ (1985) Extramammary Paget’s disease: prognosis and relationship to internal malignancy J Am Acad Dermatol 13:1009–1014PubMedCrossRef
28.
Zurück zum Zitat Allan SJ, McLaren K, Aldridge RD (1998) Paget’s disease of the scrotum: a case exhibiting positive prostate-specific antigen staining and associated prostatic adenocarcinoma. Br J Dermatol 138:689–691PubMedCrossRef Allan SJ, McLaren K, Aldridge RD (1998) Paget’s disease of the scrotum: a case exhibiting positive prostate-specific antigen staining and associated prostatic adenocarcinoma. Br J Dermatol 138:689–691PubMedCrossRef
29.
Zurück zum Zitat Archer B, Lonback JB, MacDonald DM (1998) Spontaneous regression of perianal extramammary Paget’s disease after partial surgical excision. Arch Dermatol 123:379–382CrossRef Archer B, Lonback JB, MacDonald DM (1998) Spontaneous regression of perianal extramammary Paget’s disease after partial surgical excision. Arch Dermatol 123:379–382CrossRef
30.
Zurück zum Zitat Gunn RA, Gallager HS (1980) Vulvar Paget’s disease: a topographic study. Cancer 46(3):590–594PubMedCrossRef Gunn RA, Gallager HS (1980) Vulvar Paget’s disease: a topographic study. Cancer 46(3):590–594PubMedCrossRef
31.
Zurück zum Zitat Fanning J, Lambert HC, Hale TM, et al. (1999) Paget’s disease of the vulva: prevalence of associated vulvar adenocarcinoma, invasive Paget’s disease, and recurrence after surgical excision. Am J Obstet Gynecol 180:24–27PubMedCrossRef Fanning J, Lambert HC, Hale TM, et al. (1999) Paget’s disease of the vulva: prevalence of associated vulvar adenocarcinoma, invasive Paget’s disease, and recurrence after surgical excision. Am J Obstet Gynecol 180:24–27PubMedCrossRef
32.
Zurück zum Zitat DeVita VT Jr, Hellman S, Rosenberg SA (1997) Cancers of the skin. Cancer, principles and practice of oncology. New York, Lippincott Raven, pp 1565–1566 DeVita VT Jr, Hellman S, Rosenberg SA (1997) Cancers of the skin. Cancer, principles and practice of oncology. New York, Lippincott Raven, pp 1565–1566
33.
Zurück zum Zitat Hendi A, Brodland DB, Zitelli JA (2004) Extramammary Paget’s disease: surgical treatment with Mohs micrographic surgery. J Am Acad Dermatol 51:767–773PubMedCrossRef Hendi A, Brodland DB, Zitelli JA (2004) Extramammary Paget’s disease: surgical treatment with Mohs micrographic surgery. J Am Acad Dermatol 51:767–773PubMedCrossRef
34.
Zurück zum Zitat Coldiron BM, Goldsmith BA, Robinson JK (1991) Surgical treatment of extramammary Paget’s disease. Cancer 67:933–938PubMedCrossRef Coldiron BM, Goldsmith BA, Robinson JK (1991) Surgical treatment of extramammary Paget’s disease. Cancer 67:933–938PubMedCrossRef
35.
Zurück zum Zitat Misas JE, Cold CJ, Wesley Hall F (1991) Vulvar Paget disease: fluorescein-aided visualization of margins. Obstet Gynaecol 77:156–160 Misas JE, Cold CJ, Wesley Hall F (1991) Vulvar Paget disease: fluorescein-aided visualization of margins. Obstet Gynaecol 77:156–160
36.
Zurück zum Zitat Gibson JR, Baker H, Pegum JS, et al. (1983) Multifocal extramammary Paget’s disease. J R Soc Med 76:426–427PubMed Gibson JR, Baker H, Pegum JS, et al. (1983) Multifocal extramammary Paget’s disease. J R Soc Med 76:426–427PubMed
37.
Zurück zum Zitat Lai YL, Yang WG, Tsang PK, et al. (2003) Penoscrotal extamammary Paget’s disease: A review of 33 cases in a 20 year experience. Plast Reconstr Surg 112:1017–1023PubMedCrossRef Lai YL, Yang WG, Tsang PK, et al. (2003) Penoscrotal extamammary Paget’s disease: A review of 33 cases in a 20 year experience. Plast Reconstr Surg 112:1017–1023PubMedCrossRef
38.
Zurück zum Zitat Molinie V, Paniel BJ, Lessana-Leibowitch M, et al. (1993) Paget’s disease of the vulva. 36 cases. Ann Dermatol Venereol 120:522–527PubMed Molinie V, Paniel BJ, Lessana-Leibowitch M, et al. (1993) Paget’s disease of the vulva. 36 cases. Ann Dermatol Venereol 120:522–527PubMed
39.
Zurück zum Zitat Shieh S, Dee AS, Cheney RT, et al. (2002) Photodynamic therapy for the treatment of extramammary Paget’s disease. Br J Dermatol 146:1000–1005PubMedCrossRef Shieh S, Dee AS, Cheney RT, et al. (2002) Photodynamic therapy for the treatment of extramammary Paget’s disease. Br J Dermatol 146:1000–1005PubMedCrossRef
40.
Zurück zum Zitat Burrows NP, Jones DH, Hudson PM, et al. (1995) Treatment of extramammary Paget’s disease by radiotherapy. Br J Dermatol 132:970–972PubMedCrossRef Burrows NP, Jones DH, Hudson PM, et al. (1995) Treatment of extramammary Paget’s disease by radiotherapy. Br J Dermatol 132:970–972PubMedCrossRef
41.
Zurück zum Zitat Xu H, Li N, Li W (1996) Observations on signet cell invasion and metastasis in extra-mammary Paget’s disease. Chin J Pathol 25:294–295 Xu H, Li N, Li W (1996) Observations on signet cell invasion and metastasis in extra-mammary Paget’s disease. Chin J Pathol 25:294–295
42.
Zurück zum Zitat Mohs FE, Blanchard L (1979) Microscopically controlled surgery for extramammary Paget’s disease. Arch Dermatol 115:706–708PubMedCrossRef Mohs FE, Blanchard L (1979) Microscopically controlled surgery for extramammary Paget’s disease. Arch Dermatol 115:706–708PubMedCrossRef
43.
Zurück zum Zitat Shutze WP, Gleysteen JJ (1990) Perianal Paget’s disease: classification and a review of management. Report of two cases. Dis Colon Rectum 33:502–507PubMedCrossRef Shutze WP, Gleysteen JJ (1990) Perianal Paget’s disease: classification and a review of management. Report of two cases. Dis Colon Rectum 33:502–507PubMedCrossRef
44.
Zurück zum Zitat Ray B, Whitmore WF (1977) Experience with carcinoma of the scrotum. J Urol 117(6):741–745PubMed Ray B, Whitmore WF (1977) Experience with carcinoma of the scrotum. J Urol 117(6):741–745PubMed
Metadaten
Titel
Extramammary Paget’s Disease in Chinese Males: A 21-year Experience
verfasst von
Tor W. Chiu
Pauline S. Y. Wong
Kawser Ahmed
Stephanie C. K. Lam
Shun Y. Ying
Andrew Burd
Publikationsdatum
01.10.2007
Verlag
Springer-Verlag
Erschienen in
World Journal of Surgery / Ausgabe 10/2007
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-007-9189-x

Weitere Artikel der Ausgabe 10/2007

World Journal of Surgery 10/2007 Zur Ausgabe

Invited Commentary

Invited Commentary

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.